Science & Tech 20 August 2026
New Smart Drug RK-251 Developed by IASST and IIT Guwahati as Alternative to Chemotherapy
Why in the News?
The Ministry of Science and Technology announced the development of a novel smart drug named 'RK-251', designed as a targeted replacement for traditional chemotherapy. It specifically attacks cancer cells while sparing healthy surrounding tissues.
Key Features / Major Points:
Joint Research: Developed through a collaborative effort between researchers at the Institute of Advanced Study in Science and Technology (IASST) and experts at IIT Guwahati.
Targeted Cancer Therapy: Preclinical studies have demonstrated that RK-251 exhibits strong anti-cancer activity against aggressive triple-negative breast cancer cells.
Minimized Side Effects: Unlike conventional chemotherapy that harms normal cells, RK-251 shows minimal toxicity to healthy cells, significantly reducing treatment side effects.
Static GK Facts:
Ministry of Science and Technology:
Formed: 1971
Headquarters: New Delhi
Key Departments: Department of Science & Technology (DST), Department of Scientific & Industrial Research (DSIR), Department of Biotechnology (DBT).
IASST (Institute of Advanced Study in Science and Technology):
Location: Guwahati, Assam
Status: An autonomous research institute under the Department of Science and Technology (DST).
One-Liner Quiz (All Competitive Exams):
What is the name of the new smart drug developed by IASST and IIT Guwahati as a replacement for traditional chemotherapy?
Answer: RK-251
Which specific type of cancer cells did the smart drug 'RK-251' target effectively in preclinical studies?
Answer: Triple-Negative Breast Cancer